- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Can Ellex’s 2RT Nanosecond Laser Halt the Progression of Macular Degeneration?

Posted By Dr. Ari Weitzner On February 21, 2013 @ 7:31 am In Clinical Trials,Macular Degeneration,New Technologies,Retina | 3 Comments

A new double-blind, randomized clinical trial is currently underway at the Center for Eye Research Australia (CERA) to determine whether the 2RT nanosecond laser manufactured by Ellex Medical Lasers Ltd can be utilized to slow the progression of age-related macular degeneration in patients with early stage AMD.

The laser emits a tiny pulse of energy into the back of the eye to remove the deposits that build up with age and contribute to AMD. Patients report that the treatment was completely painless.

The treatment is not suitable for people who have already developed the advanced form of AMD, either the dry or the wet form.

Click here [1] for further details about the clinical trial and here [2] for a CERA press release about the trial.

2RT-nanosecond-laser [3]


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/007050-can-ellexs-2rt-nanosecond-laser-halt-the-progression-of-macular-degeneration/

URLs in this post:

[1] Click here: http://www.clinicaltrials.gov/ct2/show/NCT01790802

[2] here: http://www.cera.org.au/news/18/143/2012-11-09/worldfirst-laser-treatment-for-australias-leading-cause-of-blindness/?page=1

[3] Image: http://eyedocnews.com/wp-content/uploads/2013/02/2RT-nanosecond-laser.jpg

Copyright © 2008 Eye Doc Talk. All rights reserved.